Want to join the conversation?
$REGN's 3Q15 total revenues increased by 57% to $1,137MM compared to 3Q14 as sales of its key eye-disease treatment accelerated. EYLEA net product sales in the U.S. were $734MM in 3Q15 compared to $445MM in 3Q14, which represents an increase of 65%. Overall distributor inventory levels remained within the Company's one-to two-week targeted range.
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)
$AGIO plunge 15%.. what's happening... is this going for a toss !